Skip to content
10-K

Annual Report

Anthera Pharmaceuticals Inc

0001214659-18-001789

← back to feed
Filed
Mar 5, 2018 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Feb 28, 2018 23.52M sh
Operating Cash Flow FY 2017 · Dec 31, 2017 −$36.9M
Operating Cash Flow FY 2017 · Dec 31, 2016 −$48.92M
Operating Cash Flow FY 2017 · Dec 31, 2015 −$30.91M
Cash And Equivalents FY 2017 · Dec 31, 2017 $2.2M
Cash And Equivalents FY 2017 · Dec 31, 2016 $20.84M
Cash And Equivalents FY 2017 · Dec 31, 2015 $46.95M
Cash And Equivalents FY 2017 · Dec 31, 2014 $2.64M
Stockholders Equity FY 2017 · Dec 31, 2017 −$5.5M
Stockholders Equity FY 2017 · Dec 31, 2016 $12.47M
Stockholders Equity FY 2017 · Dec 31, 2015 $39.66M
Stockholders Equity FY 2017 · Dec 31, 2014 −$2.26M
Current Liabilities FY 2017 · Dec 31, 2017 $4.71M
Current Liabilities FY 2017 · Dec 31, 2016 $10.62M
Total Liabilities FY 2017 · Dec 31, 2017 $9.17M
Total Liabilities FY 2017 · Dec 31, 2016 $10.62M
Current Assets FY 2017 · Dec 31, 2017 $3.19M
Current Assets FY 2017 · Dec 31, 2016 $22.71M
Total Assets FY 2017 · Dec 31, 2017 $3.67M
Total Assets FY 2017 · Dec 31, 2016 $23.47M
Sga Expense FY 2017 · Dec 31, 2017 $7.94M
Sga Expense FY 2017 · Dec 31, 2016 $11.07M
Sga Expense FY 2017 · Dec 31, 2015 $7.57M
Rd Expense FY 2017 · Dec 31, 2017 $28.59M
Rd Expense FY 2017 · Dec 31, 2016 $46.51M
Rd Expense FY 2017 · Dec 31, 2015 $33.5M
Net Income FY 2017 · Dec 31, 2017 −$26.87M
Net Income FY 2017 · Dec 31, 2016 −$55.52M
Net Income FY 2017 · Dec 31, 2015 −$35.22M
Operating Income FY 2017 · Dec 31, 2017 −$36.43M
Operating Income FY 2017 · Dec 31, 2016 −$57.18M
Operating Income FY 2017 · Dec 31, 2015 −$35.24M
Capex FY 2017 · Dec 31, 2016 $766K
Capex FY 2017 · Dec 31, 2015 $80K
Revenue FY 2017 · Dec 31, 2016 $145K
Revenue FY 2017 · Dec 31, 2015 $3.19M